No effective medical therapy is available for all patients with nonalcoholic steatohepatitis (NASH). Ursodeoxycholic acid (UDCA) has been suggested to be of benefit based on open label clinical studies. We randomized 166 patients with liver biopsy-proven NASH to receive between 13 and 15 mg/kg/d of
Clinical Trial Report: Treatment of Nonalcoholic Steatohepatitis with Vitamin E
โ Scribed by Bruce R. Bacon
- Book ID
- 107538618
- Publisher
- Springer
- Year
- 2010
- Tongue
- English
- Weight
- 59 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1522-8037
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
We consider clinical trials in which information is available about subjects' treatment changes after randomization. To understand whether any difference between randomized groups in the intention-to-treat analysis can be explained by such treatment changes, we need analysis strategies which take ac
In an open, non-randomized clinical trial conducted at multiple centres, 49 patients with rheumatoid arthritis were treated with recombinant interferon-gamma for 20 days. The study was carried out in two sub-studies. In the first, the total daily dose of interferon-gamma was 50 micrograms; in the se